BrightSpring Health Services, Inc. Common Stock (BTSG)vsMangoceuticals, Inc. Common Stock (MGRX)
BTSG
BrightSpring Health Services, Inc. Common Stock
$72.88
+5.06%
HEALTHCARE · Cap: $13.61B
MGRX
Mangoceuticals, Inc. Common Stock
$0.29
-46.88%
HEALTHCARE · Cap: $9.32M
Smart Verdict
WallStSmart Research — data-driven comparison
BrightSpring Health Services, Inc. Common Stock generates 3291462% more annual revenue ($13.65B vs $414,580). BTSG leads profitability with a 2.3% profit margin vs 0.0%. BTSG earns a higher WallStSmart Score of 53/100 (C-).
BTSG
Buy53
out of 100
Grade: C-
MGRX
Avoid23
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 359.8% YoY
Revenue surging 25.6% year-over-year
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
2.3% margin — thin
Operating margin of 3.4%
Elevated debt levels
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BTSG
The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 25.6% demonstrates continued momentum.
Bull Case : MGRX
The strongest argument for MGRX centers on Price/Book, Debt/Equity.
Bear Case : BTSG
The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 90.1x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.
Bear Case : MGRX
The primary concerns for MGRX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BTSG profiles as a growth stock while MGRX is a value play — different risk/reward profiles.
MGRX carries more volatility with a beta of 2.28 — expect wider price swings.
BTSG is growing revenue faster at 25.6% — sustainability is the question.
BTSG generates stronger free cash flow (101M), providing more financial flexibility.
Bottom Line
BTSG scores higher overall (53/100 vs 23/100) and 25.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BrightSpring Health Services, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.
Visit Website →Mangoceuticals, Inc. Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?